MPLT(MapLight Therapeutics, Inc.) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-10-15 | Kreitzer Anatol | Chief Discovery Officer | 公开市场卖出 | 12,248 | $7.84 |
| 2026-10-15 | Foff Erin Pennock | Chief Medical Officer | 公开市场卖出 | 15,355 | $8.08 |
| 2026-10-15 | Hanson Kristopher | General Counsel | 公开市场卖出 | 9,020 | $8.08 |
| 2026-10-15 | Lillie James Woodruff | Chief Scientific Officer | 公开市场卖出 | 11,513 | $8.08 |
| 2026-10-15 | GILLIS JONATHAN | CAO and Interim CFO | 公开市场卖出 | 10,167 | $8.08 |
| 2026-10-15 | Kroeger Christopher A. | Chief Executive Officer | 公开市场卖出 | 73,691 | $8.08 |
| 2026-09-16 | Hanson Kristopher | General Counsel | 公开市场卖出 | 16,509 | $11.67 |
| 2026-08-14 | Catalyst4, Inc. | 10% 股东 | 公开市场买入 | 2,928,686 | $11.38 |
| 2026-08-14 | Catalyst4, Inc. | 10% 股东 | 公开市场买入 | 4,400,000 | $11.38 |
| 2026-08-03 | Lillie James Woodruff | Chief Scientific Officer | 公开市场卖出 | 22,082 | $12.54 |
| 2026-07-30 | Catalyst4, Inc. | 10% 股东 | 公开市场买入 | 1,000,000 | $13.00 |
| 2026-07-29 | Catalyst4, Inc. | 10% 股东 | 公开市场买入 | 3,000 | $12.63 |
| 2026-07-28 | Catalyst4, Inc. | 10% 股东 | 公开市场买入 | 65,137 | $11.69 |
| 2026-07-28 | Catalyst4, Inc. | 10% 股东 | 公开市场买入 | 141,088 | $10.74 |
| 2026-07-28 | Cox Troy | 董事 | 公开市场买入 | 15,620 | $9.52 |
| 2026-07-17 | Kreitzer Anatol | Chief Discovery Officer | 公开市场卖出 | 200 | $38.39 |
| 2026-07-17 | Kreitzer Anatol | Chief Discovery Officer | 公开市场卖出 | 14,140 | $37.70 |
| 2026-07-17 | Kreitzer Anatol | Chief Discovery Officer | 公开市场卖出 | 2,833 | $37.05 |
| 2026-07-17 | GILLIS JONATHAN | CAO and Interim CFO | 公开市场卖出 | 900 | $38.17 |
| 2026-07-17 | GILLIS JONATHAN | CAO and Interim CFO | 公开市场卖出 | 16,969 | $37.61 |